NCT02715609 2025-04-10
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Washington University School of Medicine
Phase 1/2 Completed
Clinical Trials
8 trialsNCT02101008 2023-12-13
Disulfiram and Chelated Zinc for the Rx of Disseminated Mets Mel That Has Failed First Line Therapy
University of Utah
Phase 2 Completed
NCT03950830 2023-10-04
DISGCT
National Cancer Institute, Slovakia
Phase 2 Completed
NCT02770378 2021-10-05
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
University of Ulm
Phase 1/2 Completed
NCT02678975 2021-03-18
Disulfiram in Recurrent Glioblastoma
Sahlgrenska University Hospital
Phase 2/3 Completed
NCT01118741 2018-06-12
Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00256230 2016-12-08
Disulfiram in Patients With Metastatic Melanoma
University of California, Irvine
Phase 1/2 Completed
NCT00742911 2014-10-31
Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver
University of Utah
Phase 1 Completed